Infinity Bio, Inc. — Form D
Infinity Bio, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-11. The offering totals $5.0M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-03-11
- Form: D
- Accession: 0001982572-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.0M
- Remaining: $3.0M
- Investors: 2
- Date of first sale: 2025-02-18
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-540416
Issuer
- Name: Infinity Bio, Inc.
- CIK: 0001982572
- Entity type: Corporation
- Jurisdiction: UNITED STATES
- Incorporated: 2023
- Address: 6200 SEAFORTH ST., BALTIMORE, MD, 21224
- Phone: 941-586-9188
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Matthew Hellauer | Director | BALTIMORE, MD |
| Benjamin Larman | Director | Baltimore, MD |
| Joy M Nassif | Director | Baltimore, MD |
| Herman M Scholtz | Director | Baltimore, MD |
| Benjamin Larman | Executive Officer | Baltimore, MD |
| Joy M Nassif | Executive Officer | Baltimore, MD |
| Bill Benjamin Campbell | Director | Baltimore, MD |
| Caroline Popper | Director | Delray Beach, FL |
| Caroline Popper | Executive Officer | Delray Beach, FL |
| Malek Benjamin Fahem | Director | Baltimore, MD |
| H. Benjamin Larman | Director | Baltimore, MD |
| H. Benjamin Larman | Executive Officer | Baltimore, MD |
| Herman Benjamin Scholtz | Director | Baltimore, MD |
| Matthew Benjamin Hellauer | Director | Baltimore, MD |
| Joy Nassif | Director | Baltimore, MD |
| Joy Nassif | Executive Officer | Baltimore, MD |
| Herman Scholtz | Director | Baltimore, MD |
Other filings by this issuer (3)
More